{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wei X"],"funding":["Central Public Welfare Research Institutes","Hong Kong, Macao & Taiwan Science and Technology Cooperation Project","National Standardization Project of Chinese Medicine"],"pagination":["e9011"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7213012"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8"],"pubmed_abstract":["Hellebrigenin is a natural product found in the toad skin secretions and plants of Urginea, including Hellebores and Kalanchoe genera. It has been shown to be active against Leishmania chagasi promastigotes and Trypanosoma cruzi trypomastigotes and also reported to play an anti-tumor effect on several cancer cell lines in vitro, including pancreatic cancer. This study is aimed to investigate the effects of Hellebrigenin on pancreatic carcinoma cells, SW1990 and BxPC-3 in vitro and its molecular mechanism involved in antitumor activities. Our results showed that Hellebrigenin effectively inhibited the proliferation of SW1990 and BxPC-3 cells in dose- and time-dependent manner. Flow cytometry results showed that Hellebrigenin induced the G0/G1 arrest in both of SW1990 and BxPC-3 cells and pr"],"journal":["PeerJ"],"pubmed_title":["Hellebrigenin anti-pancreatic cancer effects based on apoptosis and autophage."],"pmcid":["PMC7213012"],"funding_grant_id":["ZZ10-007","2015DFM30030","ZYBZH-C-AH-01"],"pubmed_authors":["Gao B","Yang J","Si N","Bian B","He J","Han L","Wei X","Wang H","Mao Y","Zhao H"],"additional_accession":[]},"is_claimable":false,"name":"Hellebrigenin anti-pancreatic cancer effects based on apoptosis and autophage.","description":"Hellebrigenin is a natural product found in the toad skin secretions and plants of Urginea, including Hellebores and Kalanchoe genera. It has been shown to be active against Leishmania chagasi promastigotes and Trypanosoma cruzi trypomastigotes and also reported to play an anti-tumor effect on several cancer cell lines in vitro, including pancreatic cancer. This study is aimed to investigate the effects of Hellebrigenin on pancreatic carcinoma cells, SW1990 and BxPC-3 in vitro and its molecular mechanism involved in antitumor activities. Our results showed that Hellebrigenin effectively inhibited the proliferation of SW1990 and BxPC-3 cells in dose- and time-dependent manner. Flow cytometry results showed that Hellebrigenin induced the G0/G1 arrest in both of SW1990 and BxPC-3 cells and pr","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020","modification":"2026-04-07T16:18:44.693Z","creation":"2020-05-23T07:03:42Z"},"accession":"S-EPMC7213012","cross_references":{"pubmed":["32426183"],"doi":["10.7717/peerj.9011"]}}